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Objective
Clinicians have a variety of medication choices available for triggering final maturation of oocytes prior to egg retrieval. GnRH agonists with or without low doses of hCG has been increasingly popular due to its advantage of minimizing the risk of ovarian hyperstimulation syndrome (OHSS). An IVF study using GnRH agonist demonstrated an increased incidence of meiotic aberrations in non-fertilized oocytes, although the rate of aneuploidy was not significantly enhanced (Nogueira D, 2006 , Hodes Wertz B, 2015 . This study sought to explore the relationship between varying trigger strategies and ploidy outcomes in assisted reproduction technology (ART) treatment cycles.
Design

Retrospective cohort analysis
Materials and Methods
The study consisted of patients who underwent an IVF cycle(s) with preimplantation genetic screening (PGS) between January 2012 and February 2017. Only GnRH antagonist stimulation protocol cycles and patients categorized as normal responders (AMH ≥1pmol/L; basal antral follicular count ≥10; basal FSH ≤10IU/mL) were included. Oocyte donation cycles were excluded. Cycles were segregated into 4 groups (Group A: GnRh antagonist (leuprolide acetate 2mg); Group B: Dual trigger(leuprolide acetate 2mg + 1000 IU rhCG); Group C: RhCG,(250 µg); and Group D: P-hCG(10000 IU) (Figure 1 ). After adjusting for age, BMI, total number of mature oocytes and blastocysts biopsied per cycle, no association between the trigger type and ploidy outcome was observed (Table 2 ).
Conclusions
The type of trigger medication used during an IVF GnRH antagonist protocol cycles does not appear to influence ploidy outcome regardless of patient age, oocyte retrieval count, or embryos available for biopsy. The opportunity to choose triggers allows clinicians to offer patients personalized treatment approach and minimize risks of treatment including OHSS.
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